Additionally, the use of tumor cell membrane-coated responsive nanogels can induce the recruitment and maturation of DCs through a mechanism dependent on activated NK cells, ultimately stimulating the activation of CD8+ T cells for antigen-specific tumor cell killing combined with NK cell-mediated nonspecific tumor cell killing to comprehensively suppress tumor growth [80]. The gene discussed is CD8A; the disease is neoplasm.